Cancer nanomedicines: So many papers and so few drugs!
Top Cited Papers
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 65 (1), 80-88
- https://doi.org/10.1016/j.addr.2012.09.038
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Patterns of technological innovation in biotechNature Biotechnology, 2012
- Antibody-Based Immunotherapy of CancerCell, 2012
- Nanomedicine(s) under the MicroscopeMolecular Pharmaceutics, 2011
- Pfizer reaches out to academia—againNature Biotechnology, 2011
- Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphomaHaematologica, 2009
- Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular ArchitectureAccounts of Chemical Research, 2009
- Shared Idiotypes Expressed by Human B-Cell LymphomasNew England Journal of Medicine, 1989
- Invitro and invivo studies with adriamycin liposomesBiochemical and Biophysical Research Communications, 1979
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966
- Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscopeJournal of Molecular Biology, 1964